Never leave a used needle attached to the pen between doses
Diabetes Emergencies Abroad: What to Do and How to Be Ready Severe hypos and DKA hit differently when you're far from home
Wegovy (semaglutide) is an FDA-approved prescription medication for chronic weight management in adults and children 12 years and older with obesity (BMI of 30 or more) and overweight (BMI of 27 or more) with at least one weight-related condition, such as type 2 diabetes, high cholesterol, or high blood pressure
NK, RP, SL, and LA wrote the manuscript, and all authors critically revised it
Inhibition of SGLT2i may increase the sodium delivery to SMCTs thereby promoting ketone reabsorption
Patients taking semaglutide had a greater risk of developing serious stomach problems like bowel obstruction and gastroparesiswhen the stomach slows down or completely stops the movement of food to the small intestineaccording to a JAMA Ophthalmology study